Gabapentin is regularly used to treat chronic pelvic pain in women has been found to be no more effective than a placebo. The researchers say that gabapentin should no longer be considered in the treatment [...]
The U.S. Food and Drug Administration is warning that serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR) who have respiratory risk factors. These include the use [...]
Read articles about the latest pain research present at AAPM35 in Denver, March 6-10, 2019. View articles.
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources
American Academy of Pain Medicine (AAPM) is a nonprofit 501(c)(6) tax-exempt organization.
